Latest Breaking News On - மிக் ஃப்யாரெல் - Page 1 : comparemela.com

Growth stocks can be attractive additions to your long-term portfolio. However, any loss of confidence in their future performance typically leads to a significant and rapid price correction. Therefore, potential investors should do proper due diligence and be ready for volatility especially during the earnings season. Growth Stocks: Alkermes (ALKS) 52 week range: $15.35 $25.74 Ireland-based biopharma group Alkermes has a portfolio of marketed drugs and a clinical pipeline of products that address central nervous system (CNS) disorders such as schizophrenia, depression, addiction, multiple sclerosis (MS) and oncology. The company was founded in 1987. Alkermes reported earnings in late April. Revenue was $251 million, compared to $246 million for the same period in the prior year. Non-GAAP net income of $17.8 million translated into diluted earnings per share of 11 cents, big gains compared to EPS of 1 cent for the same period in the prior year. At the end of March, the company

San diegoUnited statesLong islandCrystal lakeScott thompsonMick farrellTempur sealyEric sillsInformation technologyHealth careTempur sealy internationalCommunication servicesSealy internationalMotor productsIllinois based aptargroupWeek range